These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29449427)

  • 61. The discovery of potent, orally bioavailable pyrimidine-5-carbonitrile-6-alkyl CXCR2 receptor antagonists.
    Porter DW; Bradley M; Brown Z; Charlton SJ; Cox B; Hunt P; Janus D; Lewis S; Oakley P; O'Connor D; Reilly J; Smith N; Press NJ
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3285-90. PubMed ID: 24974342
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Behavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary disease.
    Sapey E; Stockley JA; Greenwood H; Ahmad A; Bayley D; Lord JM; Insall RH; Stockley RA
    Am J Respir Crit Care Med; 2011 May; 183(9):1176-86. PubMed ID: 21257786
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat.
    Garau A; Bertini R; Mosca M; Bizzarri C; Anacardio R; Triulzi S; Allegretti M; Ghezzi P; Villa P
    Eur Cytokine Netw; 2006 Mar; 17(1):35-41. PubMed ID: 16613761
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fine-tuning neutrophil activation: Strategies and consequences.
    van der Linden M; Meyaard L
    Immunol Lett; 2016 Oct; 178():3-9. PubMed ID: 27262927
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Correlations between chymase activity, levels of tryptase, and eotaxin in the sputum of patients with chronic obstructive pulmonary disease and their clinical implications].
    Zhang XJ; He SH; Xie H; Wei JF; Liu CT
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Oct; 27(10):649-53. PubMed ID: 16200864
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The impact of cationic solid lipid nanoparticles on human neutrophil activation and formation of neutrophil extracellular traps (NETs).
    Hwang TL; Aljuffali IA; Hung CF; Chen CH; Fang JY
    Chem Biol Interact; 2015 Jun; 235():106-14. PubMed ID: 25920576
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Discovery and evaluation of a novel monocyclic series of CXCR2 antagonists.
    Austin RP; Bennion C; Bonnert RV; Cheema L; Cook AR; Cox RJ; Ebden MR; Gaw A; Grime K; Meghani P; Nicholls D; Phillips C; Smith N; Steele J; Stonehouse JP
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1616-20. PubMed ID: 25708618
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neutrophil extracellular traps are downregulated by glucocorticosteroids in lungs in an equine model of asthma.
    Vargas A; Boivin R; Cano P; Murcia Y; Bazin I; Lavoie JP
    Respir Res; 2017 Dec; 18(1):207. PubMed ID: 29233147
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Udenafil improves exercise capacity in patients with chronic obstructive pulmonary disease: a prospective study.
    Park JS; Lim HJ; Cho YJ; Lee JH; Yoon HI; Lee CT
    COPD; 2012 Aug; 9(5):499-504. PubMed ID: 22946546
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
    Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
    J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rosuvastatin treatment in stable chronic obstructive pulmonary disease (RODEO): a randomized controlled trial.
    Neukamm A; Høiseth AD; Einvik G; Lehmann S; Hagve TA; Søyseth V; Omland T
    J Intern Med; 2015 Jul; 278(1):59-67. PubMed ID: 25495178
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rabbit neutrophil chemotactic protein (NCP) activates both CXCR1 and CXCR2 and is the functional homologue for human CXCL6.
    Catusse J; Struyf S; Wuyts A; Weyler M; Loos T; Gijsbers K; Gouwy M; Proost P; Van Damme J
    Biochem Pharmacol; 2004 Nov; 68(10):1947-55. PubMed ID: 15476666
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth.
    Tazzyman S; Barry ST; Ashton S; Wood P; Blakey D; Lewis CE; Murdoch C
    Int J Cancer; 2011 Aug; 129(4):847-58. PubMed ID: 21328342
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Imaging neutrophil extracellular traps in the alveolar space and pulmonary capillaries of a murine sepsis model by multiphoton microscopy.
    Tanaka K; Toiyama Y; Inoue Y; Araki T; Mohri Y; Mizoguchi A; Kusunoki M
    Am J Respir Crit Care Med; 2015 May; 191(9):1088-9. PubMed ID: 25932768
    [No Abstract]   [Full Text] [Related]  

  • 75. Targeting both tumour-associated CXCR2
    Nywening TM; Belt BA; Cullinan DR; Panni RZ; Han BJ; Sanford DE; Jacobs RC; Ye J; Patel AA; Gillanders WE; Fields RC; DeNardo DG; Hawkins WG; Goedegebuure P; Linehan DC
    Gut; 2018 Jun; 67(6):1112-1123. PubMed ID: 29196437
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Overexpression of CD-11b and CXCR1 on circulating neutrophils: its possible role in COPD.
    Yamagata T; Sugiura H; Yokoyama T; Yanagisawa S; Ichikawa T; Ueshima K; Akamatsu K; Hirano T; Nakanishi M; Yamagata Y; Matsunaga K; Minakata Y; Ichinose M
    Chest; 2007 Sep; 132(3):890-9. PubMed ID: 17573488
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CXCR2 antagonists for the treatment of pulmonary disease.
    Chapman RW; Phillips JE; Hipkin RW; Curran AK; Lundell D; Fine JS
    Pharmacol Ther; 2009 Jan; 121(1):55-68. PubMed ID: 19026683
    [TBL] [Abstract][Full Text] [Related]  

  • 78. High-mobility group box 1 potentiates antineutrophil cytoplasmic antibody-inducing neutrophil extracellular traps formation.
    Ma YH; Ma TT; Wang C; Wang H; Chang DY; Chen M; Zhao MH
    Arthritis Res Ther; 2016 Jan; 18():2. PubMed ID: 26739852
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Statin strikeout.
    Drazen JM; Gelijns AC
    N Engl J Med; 2014 Jun; 370(23):2240-1. PubMed ID: 24835850
    [No Abstract]   [Full Text] [Related]  

  • 80. Neutrophil Oxidized-Modified Proteins and Neutrophil Extracellular Traps in Patients with Community-Acquired Pneumonia.
    Molotov-Luchanskiy V; Nukhuly A; Muravlyova L; Bakirova R; Kossybayeva A; Klyuyev D; Demidchik L; Beinikova I
    Pulm Med; 2020; 2020():4897038. PubMed ID: 33014465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.